| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Chris A Rallis is Director at FENC, with reported holdings spanning 2 companies. From August 2016 to May 2026, the filings on record show 0 open-market purchases and 17 sales. Chris A Rallis's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $702K at current prices.
Our model assigns Chris A Rallis a middling insider score of 60/100, based on 17 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +0.6%.
Chris A Rallis's largest disclosed position is in FENC as Director, worth about $675K. The FENC filings lean toward selling, a net 39,163 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE10b5-1 | 1,390 | $10.90 | $15,151.00 | -3.0% | -5.2% | -45.1% | |
| Nov 20, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sell10b5-1 | 269 | $8.25 | $2,219.25 | -0.6% | +3.3% | -49.9% | |
| Aug 18, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sell10b5-1 | 673 | $7.85 | $5,283.05 | -1.5% | +3.2% | -29.0% | |
| Jul 24, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE10b5-1 | 6,796 | $8.17 | $55,523.32 | -13.4% | -16.3% | -17.5% | |
| Jul 6, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE10b5-1 | 2,207 | $8.47 | $18,693.29 | -7.1% | -24.4% | -32.3% | |
| May 19, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sell10b5-1 | 1,758 | $7.36 | $12,938.88 | -5.4% | +5.8% | -5.8% | |
| Nov 17, 2022 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 333 | $7.99 | $2,660.67 | -1.1% | +15.5% | +1.6% |